Roberts Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,395
Closed -$364K 85
2024
Q4
$364K Hold
1,395
0.3% 72
2024
Q3
$449K Hold
1,395
0.38% 70
2024
Q2
$397K Hold
1,395
0.38% 75
2024
Q1
$397K Buy
+1,395
New +$408K 0.38% 75
2022
Q3
$337K Hold
1,496
0.49% 72
2022
Q2
$364K Hold
1,496
0.5% 72
2022
Q1
$362K Hold
1,496
0.37% 87
2021
Q4
$337K Buy
+1,496
New +$316K 0.31% 90

Other funds holding AMGN

Roberts Capital Advisors's AMGN Position: Q1 2025 in Review

Roberts Capital Advisors sold out of Amgen (AMGN) in Q1 2025, closing a stake of 1,395 shares — an estimated $364K sold.

Roberts Capital Advisors first reported a position in AMGN in Q4 2021 and held it in 8 quarters. The position peaked at $449K in Q3 2024. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Roberts Capital Advisors reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Roberts Capital Advisors sold 1,395 Amgen shares in Q1 2025, an estimated $364K.
  • Roberts Capital Advisors first reported a position in Amgen in Q4 2021 and held it in 8 quarters.
  • Roberts Capital Advisors's Amgen position peaked at $449K in Q3 2024.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Roberts Capital Advisors's 13F filing for Q1 2025, filed 13 May 2025.